Ectodermal dysplasia syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:79373
Who is this for?
Show terms as
3Active trials13Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Feb 2026Organization's Unique Protocol ID

Cairo University — NA

TrialRECRUITING
Jul 2023Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study

Pierre Fabre Medicament

TrialACTIVE NOT RECRUITING
Apr 2022Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia

EspeRare Foundation — PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Ectodermal dysplasia syndrome.

3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

3 recruitingView all trials with filters →
Phase 21 trial
Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia
Phase 2
Actively Recruiting
PI: Holm Schneider, MD (University Erlangen-Nürnberg Erlangen, Germany) · Sites: Los Angeles, California; St Louis, Missouri +6 more · Age: 1899 yrs
N/A1 trial
Organization's Unique Protocol ID
N/A
Actively Recruiting
· Sites: Cairo · Age: 1035 yrs
Other1 trial
Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study
Active
PI: Marlène Guiraud (Pierre Fabre Médicament) · Sites: Paris; Erlangen · Age: 011 yrs

Specialists

13 foundView all specialists →
DM
Dorothy K Grange, MD
SAINT LOUIS, MO
Specialist
PI on 6 active trials
IM
Ignatia B Van den Veyver, MD
Specialist
PI on 3 active trials1 Ectodermal dysplasia syndrome publication
KP
Kenneth Huttner, MD, PhD
WALTHAM, MA
Specialist
PI on 2 active trials
MM
Maegan E Roberts, MS
OCEANSIDE, CA
Specialist
PI on 1 active trial
MP
Maria Lourdes Posadas Martinez, PhD
Specialist
PI on 1 active trial
MP
Marcelo Serra, PhD
Buenos Aires, Buenos Aires
Specialist

Rare Disease Specialist

PI on 1 active trial
CB
Christine BODEMER
Bobigny
Specialist

Rare Disease Specialist

PI on 2 active trials
AP
Antoni Gostynski, MD, PhD
Maastricht, Limburg
Specialist

Rare Disease Specialist

PI on 2 active trials
SP
Steven Isakoff, MD, PhD
BOSTON, MA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Ectodermal dysplasia syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Ectodermal dysplasia syndromeForum →

No community posts yet. Be the first to share your experience with Ectodermal dysplasia syndrome.

Start the conversation →

Latest news about Ectodermal dysplasia syndrome

Disease timeline:

New recruiting trial: A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita

A new clinical trial is recruiting patients for Ectodermal dysplasia syndrome

New recruiting trial: International Pachyonychia Congenita Research Registry

A new clinical trial is recruiting patients for Ectodermal dysplasia syndrome

New recruiting trial: Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia

A new clinical trial is recruiting patients for Ectodermal dysplasia syndrome

New recruiting trial: Organization's Unique Protocol ID

A new clinical trial is recruiting patients for Ectodermal dysplasia syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Ectodermal dysplasia syndrome

Are there clinical trials for Ectodermal dysplasia syndrome?

Yes — 3 recruiting clinical trials are currently listed for Ectodermal dysplasia syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Ectodermal dysplasia syndrome?

13 specialists and care centers treating Ectodermal dysplasia syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.